EUVIMEDEUVIMED entdecken
Crossref

Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents

Seyed-Omar Zaraei, Wolfgang Dohle, Hanan S Anbar, Randa El-Gamal, Bertrand Leblond, Paul A Foster, Taleb H Al-Tel, Barry V L Potter, Mohammed I El-Gamal

Bioorganic & Medicinal Chemistry · 2024

DOI: 10.1016/j.bmc.2024.117645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2024. Verfasst von Seyed-Omar Zaraei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates. Hauptthemen laut MEDLINE: Raloxifene Hydrochloride, Breast Neoplasms, Sulfonic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: University of Sharjah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All three possible sulfamate derivatives of the selective estrogen receptor modulator Raloxifene (bis-sulfamate 7 and two mono-sulfamates 8-9) were synthesized and evaluated as inhibitors of the clinical drug target steroid sulfatase (STS), both in cell-free and in cell-based assays, and also as estrogen receptor (ER) modulators. Bis-sulfamate 7 was the most potent STS inhibitor with an IC50 of 12.2 nM in a whole JEG3 cell-based assay, with the two mono-sulfamates significantly weaker. The estrogen receptor-modulating activities of 7-9 showed generally lower affinities compared to Raloxifene HCl, diethylstilbestrol and other known ligands, with mono-sulfamate 8 being the best ligand (Ki of 1.5 nM) for ERα binding, although 7 had a Ki of 13 nM and both showed desirable antagonist activity. The antiproliferative activities of the sulfamate derivatives against the T-47D breast cancer cell line showed 7 as most potent (GI50 = 7.12 µM), comparable to that of Raloxifene. Compound 7 also showed good antiproliferative potency in the NCI-60 cell line panel with a GI50 of 1.34 µM against MDA-MB-231 breast cancer cells. Stability testing of 7-9 showed that bis-sulfamate 7 hydrolyzed by desulfamoylation at a surprisingly rapid rate, initially leading selectively to 8 and finally to Raloxifene 3 without formation of 9. The mechanisms of these hydrolysis reactions could be extensively rationalized. Conversion of Raloxifene (3) into its bis-sulfamate (7) thus produced a promising drug lead with nanomolar dual activity as an STS inhibitor and ERα antagonist, as a potential candidate for treatment of estrogen-dependent breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Raloxifene HydrochlorideBreast NeoplasmsSulfonic AcidsHumansFemaleEstrogen Receptor alphaCell Line, TumorEnzyme InhibitorsSteryl-SulfataseEstrogen Receptor Modulators

Stichwörter der Autor:innen

Enzyme inhibitionEstrogen receptorRaloxifeneSteroid sulfataseSulfamate

Substanzen

Raloxifene HydrochlorideEstrogen Receptor alphasulfamic acidEnzyme InhibitorsSteryl-SulfataseEstrogen Receptor ModulatorsSulfonic Acids

Autor:innen und Institutionen

  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Medicinal Chemistry and Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, United Kingdom.
  • Department of Pharmaceutical Sciences, Dubai Pharmacy College for Girls, Dubai 19099, United Arab Emirates.
  • Department of Medical Biochemistry, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Medicinal Chemistry, Department of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
  • Institute of Metabolism and Systems Research, 2(nd) Floor IBR Tower, University of Birmingham, Birmingham B15 2TT, United Kingdom; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingha…

Förderung

  • University of Sharjah

Zitieren

APA

Zaraei, S. O., Dohle, W., Anbar, H. S., El-Gamal, R., Leblond, B., Foster, P. A., Al-Tel, T. H., Potter, B. V. L., & El-Gamal, M. I. (2024). Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2024.117645

Vancouver

Zaraei SO, Dohle W, Anbar HS, El-Gamal R, Leblond B, Foster PA, et al. Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents. Bioorganic & Medicinal Chemistry. 2024. doi:10.1016/j.bmc.2024.117645

BibTeX
@article{Zaraei2024,
  author = {Zaraei, Seyed-Omar and Dohle, Wolfgang and Anbar, Hanan S and El-Gamal, Randa and Leblond, Bertrand and Foster, Paul A and Al-Tel, Taleb H and Potter, Barry V L and El-Gamal, Mohammed I},
  title = {Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2024},
  doi = {10.1016/j.bmc.2024.117645}
}
Kostenlos starten →